Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: Experience from a nosocomial cluster of infection

Journal of Medical Virology

Volumn 85, Issue 1, 2013, Pages 1-7

  Marzano, Alfredo ^a   Marengo, Andrea ^a   Ruggiero, Tina ^b   Allice, Tiziano ^b   Sanna, Claudia ^a   Alessandria, Carlo ^a   Morgando, Anna ^a   Sciandrello, Maria Clotilde ^a   Franzin, Anna Maria ^a   Rizzetto, Mario ^a   Ghisetti, Valeria ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

A H1N1 09; Cirrhosis; Complications; D222G; Hemagglutinin; Mutation

Indexed keywords

OSELTAMIVIR; VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL SUPERINFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPIDEMIC; FEMALE; FLU LIKE SYNDROME; GENE MUTATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFLUENZA VIRUS A H1N1; ITALY; LIVER CIRRHOSIS; MALE; MYCOSIS; OUTCOME ASSESSMENT; OUTPATIENT; PNEUMONIA; PORTAL HYPERTENSION; RISK FACTOR; TERTIARY HEALTH CARE; VIRUS STRAIN;

ADULT; CROSS INFECTION; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVAL ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 84869217517     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23454     Document Type: Article

References (23)

1. Baldanti F, Campanini G, Piralla A, Rovida F, Braschi A, Mojoli F, Iotti G, Belliato M, Conaldi PG, Arcadipane A, Pariani E, Zanetti A, Minoli L, Emmi V. 2010. Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: A multicentre study. Clin Microbiol Infect 17: 1166- 1169.
2. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708- 1719.
3. Belser JA, Jayaraman A, Raman R, Pappas C, Zeng H, Cox NJ, Katz JM, Sasisekharan R, Tumpey TM. 2011. Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS ONE 6: e25091.
4. Carcione D, Giele C, Dowse GK, Mak DB, Goggin L, Kwan K, Williams S, Smith D, Effler P. 2010. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 16: 1388- 1395.
5. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605- 2615.
6. Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, Bermingham A, McLean E, Zhao H, Bolotin S, Dar O, Watson JM, Zambon M. 2011. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveil l16: pii.19760.
7. Gaeta G, Pariani E, Amendola A, Brancaccio G, Cuomo G, Stornaiuolo G, Zappa A, Zanetti A. 2009. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 27: 3373- 3375.
8. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki H, Barman S, Webster RG, Webby RJ. 2010. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 84: 8607- 8616.
9. Kilander A, Rykkvin R, Dudman SG, Hungnes O. 2010. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15: 1- 3.
10. La Torre G, Iarocci G, Cadeddu C, Boccia A. 2010. Influence of sociodemographic inequalities and chronic conditions on influenza vaccination coverage in Italy: Results from a survey in the general population. Public Health 124: 690- 697.
11. Ledesma J, Pozo F, Ruiz MP, Navarro JM, Piñeiro L, Montes M, Castro SP, Fernandez JS, Costa JG, Fernandez M, Galan JC, Cuevas MT, Casas I, Brena PP. 2011. Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain. J Clin Virol 51: 75- 78.
12. Lee N, Chan PK, Lui GC, Wong BC, Sin WW, Choi KW, Wong RY, Lee EL, Yeung AC, Ngai KL, Chan MC, Lai RW, Yu AW, Hui DS. 2011. Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: How do they differ from those in seasonal influenza? J Infect Dis 203: 1739- 1747.
13. Leung MG, Nicoll A. 2010. Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med 7: e1000346.
14. Mimidis KP, Karatza C, Spiropoulos KV, Toulgaridis T, Charokopos NA, Thomopoulos KC, Margaritis VG, Nikolopoulou VN. 1998. Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early liver cirrhosis. Scand J Gastroenterol 33: 988- 992.
15. Newhouse EI, Xu D, Markwick PR, Amaro RE, Pao HC, Wu KJ, Alam M, McCammon JA, Li WW. 2009. Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: A molecular dynamics perspective. J Am Chem Soc 131: 17430- 17442.
16. Nunthaboot N, Rungrotmongkol T, Malaisree M, Kaiyawet N, Decha P, Sompornpisut P, Poovorawan Y, Hannongbua S. 2010. Evolution of human receptor binding affinity of H1N1 haemagglutinins from 1918 to 2009 pandemic influenza A virus. J Chem Inf Model 50: 1410- 1417.
17. Puzelli S, Facchini M, Spagnolo D, De Marco MA, Calzoletti L, Zanetti A, Fumagalli R, Tanzi ML, Cassone A, Rezza G, Donatelli I. 2010. Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis 16: 863- 865.
18. Song JY, Cheong HJ, Ha SH, Hwang IS, Kee SY, Jeong HW, Lee CG, Kim WJ. 2007. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clin Virol 39: 159- 163.
19. Valenti A, Caimi G. 2010. Physiopathological, clinical and therapeutic aspects of hepatopulmonary syndrome. Clin Ther 161: 123- 128.
20. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzalez C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, Haas W, Bonmarin I, Taniguichi K, Nakajima K, Shobayashi T, Takayama Y, Sunagawa T, Heraud JM, Orelle A, Palacios E, van der Sande MA, Wielders CC, Hunt D, Cutter J, Lee VJ, Thomas J, Santa-Olalla P, Sierra-Moros MJ, Hanshaoworakul W, Ungchusak K, Pebody R, Jain S, Mounts AW. 2011. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med 8: e1001053.
21. Viasus D, Pano-Pardo JR, Pachon J, Campins A, Lopez-Medrano F, Villoslada A, Farinas MC, Moreno A, Rodriguez-Bano J, Oteo JA, Martinez-Montauti J, Torre-Cisneros J, Segura F, Gudiol F, Carratalà J. 2011. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 17: 738- 746.
22. World Health Organization Pandemic (H1N1). 2010. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html/
23. Zimmer S, Burke D. 2009. Historical perspectives-emergence of influenza A (H1N1) viruses. N Engl J Med 361: 279- 285.